Evidence map›Paper›PMID 26792617›Full record

ArticleScientific reports2016

Urinary Kininogen-1 and Retinol binding protein-4 respond to Acute Kidney Injury: predictors of patient prognosis?

Laura Gonzalez-Calero, Marta Martin-Lorenzo, Angeles Ramos-Barron, Jorge Ruiz-Criado, Aroa S Maroto, Alberto Ortiz, Carlos Gomez-Alamillo, Manuel Arias, Fernando Vivanco, Gloria Alvarez-Llamas

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
1.8field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 32 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Review
  7. Article
  8. The Clinical Significance of Urinary Retinol-Binding Protein 4: A Review.International journal of environmental research and public health · 2022
    Review
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 4 institutions in 1 country.

Laura Gonzalez-CaleroDepartment of Immunology, IIS-Fundacion Jimenez Diaz-UAM, REDinREN, Madrid, Spain.
Marta Martin-LorenzoDepartment of Immunology, IIS-Fundacion Jimenez Diaz-UAM, REDinREN, Madrid, Spain.
Angeles Ramos-BarronNephrology Department, Valdecilla Hospital, University of Cantabria, Instituto de Formación e Investigación Marqués de Valdecilla, IDIVAL, Santander, Cantabria, Spain.
Jorge Ruiz-CriadoNephrology Department, Valdecilla Hospital, University of Cantabria, Instituto de Formación e Investigación Marqués de Valdecilla, IDIVAL, Santander, Cantabria, Spain.
Aroa S MarotoDepartment of Immunology, IIS-Fundacion Jimenez Diaz-UAM, REDinREN, Madrid, Spain.
Alberto OrtizDepartment of Nephrology/IRSIN, IIS-Fundación Jiménez Díaz, School of Medicine, UAM, Madrid, Spain.
Carlos Gomez-AlamilloNephrology Department, Valdecilla Hospital, University of Cantabria, Instituto de Formación e Investigación Marqués de Valdecilla, IDIVAL, Santander, Cantabria, Spain.
Manuel AriasNephrology Department, Valdecilla Hospital, University of Cantabria, Instituto de Formación e Investigación Marqués de Valdecilla, IDIVAL, Santander, Cantabria, Spain.
Fernando VivancoDepartment of Immunology, IIS-Fundacion Jimenez Diaz-UAM, REDinREN, Madrid, Spain.
Gloria Alvarez-LlamasDepartment of Immunology, IIS-Fundacion Jimenez Diaz-UAM, REDinREN, Madrid, Spain.
Universidad Autónoma de Madrid · ESHospital Universitario Fundación Jiménez Díaz · ESInstituto de Investigación Marqués de Valdecilla · ESUniversidad de Cantabria · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Implementation of therapy for acute kidney injury (AKI) depends on successful prediction of individual patient prognosis. Clinical markers as serum creatinine (sCr) have limitations in sensitivity and early response. The aim of the study was to identify novel molecules in urine which show altered levels in response to AKI and investigate their value as predictors of recovery. Changes in the urinary proteome were here investigated in a cohort of 88 subjects (55 AKI patients and 33 healthy donors) grouped in discovery and validation independent cohorts. Patients' urine was collected at three time points: within the first 48 h after diagnosis(T1), at 7 days of follow-up(T2) and at discharge of Nephrology(T3). Differential gel electrophoresis was performed and data were confirmed by Western blot (WB), liquid chromatography/mass spectrometry (LC-MS/MS) and enzyme-linked immunosorbent assay (ELISA). Retinol binding protein 4 (RBP4) and kininogen-1 (KNG1) were found significantly altered following AKI. RBP4 increased at T1, and progressively decreased towards normalization. Maintained decrease was observed for KNG1 from T1. Individual patient response along time revealed RBP4 responds to recovery earlier than sCr. In conclusion, KNG1 and RBP4 respond to AKI. By monitoring RBP4, patient's recovery can be anticipated pointing to a role of RBP4 in prognosis evaluation.

Indexed as

Acute Kidney InjuryAdolescentAdultAgedAged, 80 and overBiomarkersComorbidityCreatinineFemaleHumansKininogensMaleMiddle AgedPrognosisRetinol-Binding Proteins, PlasmaROC CurveBiomarkersCreatinineKininogensKNG1 protein, humanRBP4 protein, humanRetinol-Binding Proteins, Plasma

Identifiers

PMID26792617
PMCPMC4726181
OpenAlexW2275568719

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.